Beyond The Numbers: 8 Analysts Discuss Health Catalyst Stock
Latest Ratings for HCAT Date Firm Action From To Mar 2022 Piper Sandler Maintains Overweight Mar 2022 Raymond James Maintains Strong Buy Mar 2022 Canaccord Genuity Maintains Buy View More Analyst Ratings for HCAT View the Latest Analyst Ratings read more